WuXi PharmaTech Healthcare Fund I L.P. 13D and 13G filings for Adagene Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:26 pm Sale | 2026-03-31 | 13G | ADAGENE INC ADS ADAG | WuXi PharmaTech Healthcare Fund I L.P. | 3,485,038 5.900% | -636,777 (-15.45%) | Filing |
| 2025-11-14 5:42 pm Sale | 2025-09-30 | 13G | ADAGENE INC ADS ADAG | WuXi PharmaTech Healthcare Fund I L.P. | 4,121,815 7.000% | -856,813 (-17.21%) | Filing |
| 2025-05-15 5:29 pm Sale | 2025-03-31 | 13G | ADAGENE INC ADS ADAG | WuXi PharmaTech Healthcare Fund I L.P. | 4,978,628 8.500% | -303,492 (-5.75%) | Filing |
| 2022-01-26 06:09 am Purchase | 2021-12-31 | 13G | ADAGENE INC ADS ADAG | WuXi PharmaTech Healthcare Fund I L.P. | 5,282,120 9.670% | 5,282,120 (New Position) | Filing |